Results You Can Trust. Fast.

We provide accurate molecular testing with superior PCR turnaround times, typically 24-48 hours.

There is no substitute for experience. We have been performing nucleic acid amplification (NAA) testing via PCR and related methods for over 15 years, well before PCR became part of the vernacular. We use NAA methods, including PCR (polymerase chain reaction) and TMA (transcription mediated amplification), to test and identify infections from bacterial, viral, fungal and parasitic organisms. We perform this testing on FDA cleared platforms as well as on assays developed by our scientific team. Over the years we developed over 25 PCR assays offered on a diverse range of collection media for vaginal, gastrointestinal, and respiratory specimens.

PCR Testing. The “Gold Standard”
  • NAA (nucleic acid amplification) testing is the gold standard for detecting pathogenic organisms; includes PCR (polymerase chain reaction) and TMA (transcription mediated amplification) which are equivalent amplification technique.
  • Results within 24 hours from receipt of specimen collection.
  • 26 tests for bacteria, viruses, fungii, and parasites.
  • Vaginal, GI, Respiratory specimens.
  • FDA cleared and Laboratory Developed assays.
  • Quantitative identification for selected organisms.
  • Informative reports.
Accuracy &
  • Wide range of collection and trasnsport media.
  • For vaginal collections, our tests are validated off the Pap vial (Hologic ThinPrep® and BD SurePath®).
  • Top testing platforms with high levels of automation:
    • BD Max
    • Hologic Panther
    • Roche Cobas
    • Thermo Quant Studio 7
  • 99%+ sensitivity and specificity, and low LOD (lower level of detection) levels (see individual assays for specific data).
All Insurances
  • Accept virtually all insurances.
  • Uninsured patients can still be tested.
  • Special pricing for self-pay patients.
  • Tests individually orderable minimize cost to insurance and patients by avoiding large panels.
Quality Innovations. Trusted Results.
  • PCR testing is all about the details. Over the years, our scientific team introduced features and innovations to address or answer the following diagnostic questions:
  • What are the proper clinical cutoffs?
  • How do we ensure proper specimen collection to rule out false negative results due to inadequate collection?
  • What is the best media for testing as organisms in a specimen could continue to grow post-collection and could give an incorrect picture for the patient.
  • Could we have useful testing pathways that are also cost effective for patients and insurance companies? Can tests be ordered individually? Could we add more tests after initial results?